Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome-lysosome Fusion in NSCLC.

Guo, Weina; Zhou, Haifeng; Wang, Jingbo; Lu, Junjie; Dong, Yalan; Kang, Zhenyu; Qiu, Xiaoyuan; Ouyang, Xiaohu; Chen, Qianyun; Li, Junyi; Cheng, Xiang; Du, Keye; Li, Mingyue; Lin, Zhihao; Jin, Min; Zhang, Lei; Sarapultsev, Alexey; Shi, Kuangyu; Li, Fangfei; Zhang, Ge; ... (2024). Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome-lysosome Fusion in NSCLC. Advanced science, 11(31), e2308307. Wiley 10.1002/advs.202308307

[img]
Preview
Text
Advanced_Science_-_2024_-_Guo_-_Aloperine_Suppresses_Cancer_Progression_by_Interacting_with_VPS4A_to_Inhibit.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (9MB) | Preview

Aloperine (ALO), a quinolizidine-type alkaloid isolated from a natural Chinese herb, has shown promising antitumor effects. Nevertheless, its common mechanism of action and specific target remain elusive. Here, it is demonstrated that ALO inhibits the proliferation and migration of non-small cell lung cancer cell lines in vitro and the tumor development in several mouse tumor models in vivo. Mechanistically, ALO inhibits the fusion of autophagosomes with lysosomes and the autophagic flux, leading to the accumulation of sequestosome-1 (SQSTM1) and production of reactive oxygen species (ROS), thereby inducing tumor cell apoptosis and preventing tumor growth. Knockdown of SQSTM1 in cells inhibits ROS production and reverses ALO-induced cell apoptosis. Furthermore, VPS4A is identified as a direct target of ALO, and the amino acids F153 and D263 of VPS4A are confirmed as the binding sites for ALO. Knockout of VPS4A in H1299 cells demonstrates a similar biological effect as ALO treatment. Additionally, ALO enhances the efficacy of the anti-PD-L1/TGF-β bispecific antibody in inhibiting LLC-derived subcutaneous tumor models. Thus, ALO is first identified as a novel late-stage autophagy inhibitor that triggers tumor cell death by targeting VPS4A.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Shi, Kuangyu

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2198-3844

Publisher:

Wiley

Language:

English

Submitter:

Pubmed Import

Date Deposited:

22 Aug 2024 11:05

Last Modified:

23 Aug 2024 07:01

Publisher DOI:

10.1002/advs.202308307

PubMed ID:

39166458

Uncontrolled Keywords:

VPS4A apoptosis autophagy inhibition non‐small cell lung cancer sequestosome‐1

BORIS DOI:

10.48350/199907

URI:

https://boris.unibe.ch/id/eprint/199907

Actions (login required)

Edit item Edit item
Provide Feedback